Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (191-200 of 290) with videos related to

Pageof 29
Sort By:
Cancers|November 4, 2020
Marked Increased Production of Acute Phase Reactants by Skeletal Muscle during Cancer CachexiaIsabelle S Massart, Geneviève Paulissen, Audrey Loumaye, et al.
United European Gastroenterology Journal|May 19, 2018
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonistsMartine De Vos, Barbara Dhooghe, Severine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2010
Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapyJean-François Rahier, Sébastien Buche, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|July 9, 2019
Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's DiseaseNicolas Pierre, Catherine Salée, Charlotte Massot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 15, 2025
Long-Term Safety of Vedolizumab in Patients With Ulcerative Colitis/Crohn's Disease: A Prospective Observational StudyEdouard Louis, Shaji Sebastian, Britta Siegmund, et al.
Journal of Crohn'S & Colitis|April 13, 2016
Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's DiseasePhilippe Marteau, David Laharie, Jean-Frédéric Colombel, et al.
Digestive Diseases and Sciences|November 8, 2025
Management of Patients with Ulcerative Proctitis: A Global SurveyBénédicte Caron, Léa Sequier, Axel Dignass, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and DysplasiaAnneline Cremer, Pieter Demetter, Martine De Vos, et al.
Journal of Crohn'S & Colitis|February 16, 2013
Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's diseaseGert Van Assche, Karin A Herrmann, Edouard Louis, et al.
International Journal of Colorectal Disease|October 31, 2014
The course of anaemia in children and adolescents with Crohn's disease included in a prospective registryStephanie Van Biervliet, Françoise Smets, Ilse Hofmann, et al.
Pageof 29

Showing results (191-200 of 290) with videos related to

Sort By:
Pageof 29
Cancers|November 4, 2020
Marked Increased Production of Acute Phase Reactants by Skeletal Muscle during Cancer CachexiaIsabelle S Massart, Geneviève Paulissen, Audrey Loumaye, et al.
United European Gastroenterology Journal|May 19, 2018
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonistsMartine De Vos, Barbara Dhooghe, Severine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2010
Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapyJean-François Rahier, Sébastien Buche, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|July 9, 2019
Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's DiseaseNicolas Pierre, Catherine Salée, Charlotte Massot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 15, 2025
Long-Term Safety of Vedolizumab in Patients With Ulcerative Colitis/Crohn's Disease: A Prospective Observational StudyEdouard Louis, Shaji Sebastian, Britta Siegmund, et al.
Journal of Crohn'S & Colitis|April 13, 2016
Interobserver Variation Study of the Rutgeerts Score to Assess Endoscopic Recurrence after Surgery for Crohn's DiseasePhilippe Marteau, David Laharie, Jean-Frédéric Colombel, et al.
Digestive Diseases and Sciences|November 8, 2025
Management of Patients with Ulcerative Proctitis: A Global SurveyBénédicte Caron, Léa Sequier, Axel Dignass, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2019
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and DysplasiaAnneline Cremer, Pieter Demetter, Martine De Vos, et al.
Journal of Crohn'S & Colitis|February 16, 2013
Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's diseaseGert Van Assche, Karin A Herrmann, Edouard Louis, et al.
International Journal of Colorectal Disease|October 31, 2014
The course of anaemia in children and adolescents with Crohn's disease included in a prospective registryStephanie Van Biervliet, Françoise Smets, Ilse Hofmann, et al.
Pageof 29